These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9209734)

  • 1. Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia.
    Akiyoshi J; Isogawa K; Tsutsumi T; Kasturagi S; Kohno K; Furuta M; Yamamoto Y; Yamada K; Fujii I
    Biol Psychiatry; 1997 Jul; 42(2):151-4. PubMed ID: 9209734
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCK-4-induced calcium mobilization in T cells is enhanced in panic disorder.
    Akiyoshi J; Moriyama T; Isogawa K; Miyamoto M; Sasaki I; Kuga K; Yamamoto H; Yamada K; Fujii I
    J Neurochem; 1996 Apr; 66(4):1610-6. PubMed ID: 8627317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder.
    Kato T; Wang ZW; Zoega T; Crowe RR
    Am J Med Genet; 1996 Jul; 67(4):401-5. PubMed ID: 8837709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
    Bertoglio LJ; Zangrossi H
    Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects.
    Lydiard RB; Ballenger JC; Laraia MT; Fossey MD; Beinfeld MC
    Am J Psychiatry; 1992 May; 149(5):691-3. PubMed ID: 1575262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.
    Koszycki D; Torres S; Swain JE; Bradwejn J
    Psychosom Med; 2005; 67(4):590-5. PubMed ID: 16046372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
    Abelson JL; Nesse RM
    Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin induces cerebral vasodilatation via presynaptic CCK2 receptors: new implications for the pathophysiology of panic.
    Sánchez-Fernández C; González C; Mercer LD; Beart PM; Ruiz-Gayo M; Fernández-Alfonso MS
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):364-70. PubMed ID: 12621311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety.
    Schunck T; Erb G; Mathis A; Gilles C; Namer IJ; Hode Y; Demaziere A; Luthringer R; Macher JP
    Neuroimage; 2006 Jul; 31(3):1197-208. PubMed ID: 16600640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cholecystokinin hypothesis of anxiety and panic disorder.
    Bradwejn J; Koszycki D
    Ann N Y Acad Sci; 1994 Mar; 713():273-82. PubMed ID: 8185169
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitivity to cholecystokinin-tetrapeptide in major depression.
    Koszycki D; Copen J; Bradwejn J
    J Affect Disord; 2004 Jun; 80(2-3):285-90. PubMed ID: 15207943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobiological investigations into the role of cholecystokinin in panic disorder.
    Bradwejn J
    J Psychiatry Neurosci; 1993 Jul; 18(4):178-88. PubMed ID: 8104032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients.
    van Megen HJ; Westenberg HG; den Boer JA
    Biol Psychiatry; 1996 Oct; 40(8):804-6. PubMed ID: 8894076
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7.
    Binkley K; King N; Poonai N; Seeman P; Ulpian C; Kennedy J
    J Allergy Clin Immunol; 2001 May; 107(5):887-90. PubMed ID: 11344357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder.
    Plag J; Gaudlitz K; Zschucke E; Yassouridis A; Pyrkosch L; Wittmann A; Holsboer F; Ströhle A
    Curr Pharm Des; 2012; 18(35):5619-26. PubMed ID: 22632477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms.
    Le Mellédo JM; Bradwejn J; Koszycki D; Bichet DG; Bellavance F
    Biol Psychiatry; 1998 Sep; 44(5):364-6. PubMed ID: 9755359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic function in panic disorder: comparison with major and minor depression.
    Pitchot W; Ansseau M; Gonzalez Moreno A; Hansenne M; von Frenckell R
    Biol Psychiatry; 1992 Dec; 32(11):1004-11. PubMed ID: 1467380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon dioxide induces erratic respiratory responses in bipolar disorder.
    Mackinnon DF; Craighead B; Lorenz L
    J Affect Disord; 2009 Jan; 112(1-3):193-200. PubMed ID: 18495250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.